Drugs / PBSC
last change Oct 2011 re-read 2 minutes ago

PBSC

Developed for
leukemia · lymphoma
Investigated by
Cancer and Leukemia Group B · National Cancer Institute (NCI)

Trials 1 · a red edge is where a trial was stopped

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00006252 Feb 2001 → Jan 2007 leukemia, lymphoma Cancer and Leukemia Group B Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PBSC ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006252
Route Intravenous “via infusion on Day 0” NCT00006252